CloseClose
Moving quickly
At the outset of the outbreak, our researchers at Imperial quickly repurposed their equipment to provide testing for Covid-19
Find out more
NextFind out more
We strive to bring forward the day when we can prevent, slow and ultimately stop the diseases which cause dementia.
But we also use our expertise to support people affected by dementia now.
People with dementia most often want to live independently, but making somebody’s home safe can be a challenge. Our Care Research & Technology centre develops innovative tools and technologies to assist with care at home. Easy-to-use smart technologies can monitor the home and alert medical professionals, for example when sleep patterns are disturbed, or infections detected. That reduces the risk of hospitalisation, benefitting both individuals and the wider health and care system.
No group was hit harder by Covid-19 than people with dementia. The UK DRI moved quickly to help, repurposing our equipment for testing and working with policymakers to ensure lessons were learned. And now we are focused on understanding the long-term impacts of the Covid-19 on the brain, so we can be prepared for months and years to come.
Until we know how to stop dementia, enabling people to live with a good quality of life is a top priority. Dr Nir Grossman and his team at the UK DRI at Imperial look at non-invasive ways to treat symptoms of dementia. That includes using electrical currents to stimulate areas deep within the brain, potentially helping with the tremors and stiffness which can accompany dementias. Dr Grossman’s team has launched a landmark trial into whether this technique might help individuals with Alzheimer’s.
We are devoted to transforming the lives of people living with neurodegenerative diseases by pioneering non-invasive neuromodulatory interventions.
© UK DRI Ltd. Company No. 11045257
Charity No. 1179589
